Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grabowski

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Anticancer Research|August 8, 2009
Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independentSusan A J Vaziri, Dale R Grabowski, Jason Hill, et al.
Child Maltreatment|January 27, 2021
Integrating Animal-Assisted Therapy Into TF-CBT for Abused Youth With PTSD: A Randomized Controlled Feasibility TrialBrian Allen, Chad E Shenk, Nancy E Dreschel, et al.
Anticancer Research|December 12, 2003
c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosisSusan A Vaziri, Dale R Grabowski, Masahiro Tabata, et al.
Anticancer Research|July 11, 2006
Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanismsNagio Takigawa, Susan A J Vaziri, Dale R Grabowski, et al.
Molecular Pharmacology|November 26, 1999
Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposideD R Grabowski, K A Holmes, M Aoyama, et al.
The Journal of Biological Chemistry|September 29, 2001
Topoisomerase II poisoning by ICRF-193K C Huang, H Gao, E F Yamasaki, et al.
Current Eye Research|July 18, 2003
Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitisS D Trocme, K M Leiferman, T George, et al.
The Biochemical Journal|December 8, 1998
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalphaM Aoyama, D R Grabowski, G R Dubyak, et al.
Nucleic Acids Research|December 2, 2008
Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activityAdrian G Grozav, Kenichi Chikamori, Toshiyuki Kozuki, et al.
Blood|October 9, 1998
Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cellsM Aoyama, D R Grabowski, R J Isaacs, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Anticancer Research|August 8, 2009
Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independentSusan A J Vaziri, Dale R Grabowski, Jason Hill, et al.
Child Maltreatment|January 27, 2021
Integrating Animal-Assisted Therapy Into TF-CBT for Abused Youth With PTSD: A Randomized Controlled Feasibility TrialBrian Allen, Chad E Shenk, Nancy E Dreschel, et al.
Anticancer Research|December 12, 2003
c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosisSusan A Vaziri, Dale R Grabowski, Masahiro Tabata, et al.
Anticancer Research|July 11, 2006
Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanismsNagio Takigawa, Susan A J Vaziri, Dale R Grabowski, et al.
Molecular Pharmacology|November 26, 1999
Altered drug interaction and regulation of topoisomerase IIbeta: potential mechanisms governing sensitivity of HL-60 cells to amsacrine and etoposideD R Grabowski, K A Holmes, M Aoyama, et al.
The Journal of Biological Chemistry|September 29, 2001
Topoisomerase II poisoning by ICRF-193K C Huang, H Gao, E F Yamasaki, et al.
Current Eye Research|July 18, 2003
Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitisS D Trocme, K M Leiferman, T George, et al.
The Biochemical Journal|December 8, 1998
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalphaM Aoyama, D R Grabowski, G R Dubyak, et al.
Nucleic Acids Research|December 2, 2008
Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activityAdrian G Grozav, Kenichi Chikamori, Toshiyuki Kozuki, et al.
Blood|October 9, 1998
Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cellsM Aoyama, D R Grabowski, R J Isaacs, et al.
Pageof 9